rs72468699

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004006.3(DMD):​c.1337A>G​(p.His446Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000217 in 1,202,965 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. H446H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., 9 hem., cov: 21)
Exomes 𝑓: 0.00022 ( 0 hom. 90 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

3
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 6.66

Publications

3 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055550426).
BP6
Variant X-32614448-T-C is Benign according to our data. Variant chrX-32614448-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 94461.
BS2
High AC in GnomAd4 at 24 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.1337A>G p.His446Arg missense_variant Exon 12 of 79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.1337A>G p.His446Arg missense_variant Exon 12 of 79 1 NM_004006.3 ENSP00000354923.3

Frequencies

GnomAD3 genomes
AF:
0.000216
AC:
24
AN:
110892
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000966
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00266
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000758
Gnomad OTH
AF:
0.00201
GnomAD2 exomes
AF:
0.000297
AC:
53
AN:
178462
AF XY:
0.000391
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000259
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00167
Gnomad NFE exome
AF:
0.000228
Gnomad OTH exome
AF:
0.000228
GnomAD4 exome
AF:
0.000217
AC:
237
AN:
1092073
Hom.:
0
Cov.:
29
AF XY:
0.000251
AC XY:
90
AN XY:
358887
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26180
American (AMR)
AF:
0.000200
AC:
7
AN:
34974
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19253
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30078
South Asian (SAS)
AF:
0.0000371
AC:
2
AN:
53838
European-Finnish (FIN)
AF:
0.00179
AC:
72
AN:
40114
Middle Eastern (MID)
AF:
0.000487
AC:
2
AN:
4107
European-Non Finnish (NFE)
AF:
0.000170
AC:
142
AN:
837760
Other (OTH)
AF:
0.000262
AC:
12
AN:
45769
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000216
AC:
24
AN:
110892
Hom.:
0
Cov.:
21
AF XY:
0.000271
AC XY:
9
AN XY:
33266
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30557
American (AMR)
AF:
0.0000966
AC:
1
AN:
10357
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2626
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3490
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2650
European-Finnish (FIN)
AF:
0.00266
AC:
16
AN:
6019
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
0.0000758
AC:
4
AN:
52786
Other (OTH)
AF:
0.00201
AC:
3
AN:
1491
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000133
Hom.:
2
Bravo
AF:
0.0000718
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000297
AC:
36

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 3B Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Left ventricular noncompaction cardiomyopathy Uncertain:1
Sep 29, 2014
Blueprint Genetics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary dilated cardiomyopathy Uncertain:1
Sep 29, 2014
Blueprint Genetics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Jun 26, 2018
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
May 23, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19937601, 28416588) -

DMD-related disorder Benign:1
Aug 30, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Duchenne muscular dystrophy Benign:1
Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 18, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Benign
-0.080
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
.;T;.;.;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.92
D;.;D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.056
T;T;T;T;T
MetaSVM
Benign
-0.33
T
PhyloP100
6.7
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-4.9
.;D;.;D;D
REVEL
Uncertain
0.37
Sift
Uncertain
0.0030
.;D;.;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;T
Polyphen
0.99, 1.0
.;D;.;.;D
Vest4
0.78
MVP
0.85
MPC
0.080
ClinPred
0.40
T
GERP RS
5.6
gMVP
0.82
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72468699; hg19: chrX-32632565; API